Tag Archives: Angelman syndrome

October, 2017

  • 20 October

    Agilis Presents Data from its Gene Therapy Program for Angelman Syndrome

    CAMBRIDGE, Mass.–(BUSINESS WIRE)–Agilis Biotherapeutics, Inc. (Agilis), a biotechnology company advancing innovative DNA therapeutics for rare genetic diseases that affect the central nervous system (CNS), announced today two presentations on its gene therapy program for Angelman syndrome (AS). A poster presentation entitled, “The A-BOM: Collaborating to identify patient-centered biomarkers and outcome …

September, 2016

November, 2015